ADAM12 promotes the resistance of lung adenocarcinoma cells to EGFR-TKI and regulates the immune microenvironment by activating PI3K/Akt/mTOR and RAS signaling pathways
- Resource Type
- Article
- Source
- In
International Immunopharmacology September 2023 122 - Subject
- Language
- ISSN
- 1567-5769